Meddenovo
Lyon, FR · Founded 2023 · 1 known investors
Meddenovo develops Mexa, an AI-powered platform for de novo design of cyclic peptide drug candidates. The company serves pharmaceutical partners seeking to discover novel peptide therapeutics for oncology, radiopharmaceuticals, and metabolic diseases.
AI & Machine LearningBiotechDeep Tech
Investors · 1
Frequently asked questions
- What does Meddenovo do?
- Meddenovo develops Mexa, an AI-powered platform for de novo design of cyclic peptide drug candidates. The company serves pharmaceutical partners seeking to discover novel peptide therapeutics for oncology, radiopharmaceuticals, and metabolic diseases.
- Who are Meddenovo's investors?
- Meddenovo's investors include ACT Venture Partners.
- Where is Meddenovo headquartered?
- Meddenovo is headquartered in Lyon, FR.